Arine

Arine is an AI-driven SaaS platform company focused on medication intelligence. Founded in 2017 by Yoona Kim and Penjit "Boom" Moorhead, the company's mission is to ensure that every individual receives the safest, most effective, and most appropriate treatment for their unique and evolving healthcare needs. Arine's platform leverages artificial intelligence, machine learning, and deep clinical expertise to analyze clinical, social, and behavioral data. This enables the identification and resolution of medication-related problems at scale, helping health plans and at-risk providers improve patient outcomes and reduce healthcare costs. The company's solutions aim to optimize medication therapy by providing personalized care plans and just-in-time interventions. Arine's technology synthesizes complex patient data to address issues such as suboptimal drug dosing, dangerous drug combinations, and inappropriate drug choices, thereby preventing adverse events and unnecessary hospitalizations.

Arine has demonstrated significant growth and impact in the healthcare industry. The company partners with numerous health plans, including national payers, Blue Cross/Blue Shield plans, and Medicaid and Medicare Advantage plans, managing millions of lives. Arine's platform has been shown to reduce hospitalizations by up to 40% and decrease the total cost of care by 10-15% for its clients. The company has been recognized for its rapid growth, ranking 236th overall and 5th in the AI category on the 2024 Inc. 5000 list of America's fastest-growing private companies. Arine's commitment to innovation and its people-forward culture have been central to its success. The company emphasizes a collaborative environment where data scientists, engineers, pharmacists, and developers work together to build and refine its medication intelligence platform. Arine is headquartered in San Francisco, California, and supports a remote workforce across the United States, reflecting its modern approach to operations and talent acquisition. The company continues to expand its capabilities and partnerships to further enhance value-based care and improve the health and well-being of patients nationwide.